·   Log in

Siro expands base in Asia-Pacific region through forging pact with Taiwan-based Virginia

Tagged with:
Friday, April 23, 2010, 21:23 This news item was posted in Clinical Trials category and has 0 Comments so far.

Siro Clinpharm, a leading contract research organization  from India, has forged an alliance with Virginia Contract Research Organization Co, Ltd (VCRO), a Taiwan-based CRO.

Virginia has more than a decade’s experience in the clinical research field and has full-service clinical service capabilities including EDC, IVRS and analytical laboratory services.

“This alliance is a collaborative partnership wherein both Siro and VCRO will draw into each others strengths to offer enhanced services to their customers. Siro will now be able to offer greater reach for patient recruitment in the region,” stated Ajit Nair, president, Siro, India operations.

VCRO has extensive network in the Asia-Pacific regions including Japan, China, Singapore and Hong Kong.

The clinical trials market in Taiwan is an attractive destination for global pharma-biotech firms. Taiwan offers conducive regulatory environment and trained manpower, according to Siro officials.

Recently, Siro Clinpharm has opened an office in Prague, Czech Republic.

Siro Clinpharma plans to offer clinical research services including clinical monitoring, biostatistics and statistical programming, from its Prague office.

Siro started its European operations in April 2008 with the acquisition of Omega Mediation, a Germany based CRO. Siro acquired 100% stake, in an all cash deal, with the companies within the Omega Mediation Group, a leading mid-sized CRO.

The acquisition was expected to provide Siro with operational capabilities in 5 key European Countries and Israel and access to Omega’s clients with major European pharmaceutical and biotech clients.

Subsequently Siro has expanded its reach through starting operations in North East and South East Europe.

Siro is a leading contract research organization from India with multinational operations. With a presence in over 15 countries across North America, Europe and Asia, Siro offers global bio-technology.

Siro offers a range services related to clinical drug development process including feasibility and patient access planning, project management and planning, clinical monitoring, medical services, clinical audit services and quality assurance, site contract management, clinical resourcing, investigator recruitment, CRF design, clinical data management, biostatistics and medical writing.

Siro Clinpharma entered into an alliance with CambReg Regulatory Services, a UK based pan-European regulatory services provider, offer regulatory services for small and midsized companies in the European markets, in August.

Before that in April, Siro ClinPharm forged an alliance  with oncology drug development service provider Advanced Clinical Trial Solutions LLC (ACT Solutions) of USA.

The Flemington, NJ-based ACT Solutions, which offers services in developing cancer therapeutics, is concentrated in the North American market.

This alliance will enable SIRO to expand its oncology clinical development and patient recruitment expertise to North America. ACT Solutions and its clients will benefit by gaining access to Siro’s clinical study management, patient recruitment, data management, biostatistics and medical writing capabilities in India and European countries.

In early July, 2007 SIRO acquired Global Client Partners (GCP), a US based CRO with strong client networks among the US biotech and pharma companies.

Quite recently, Siro has set up its office in Princeton, NJ, with an objective to reach strategic customers in North America.

Siro Clinpharm has offices in US, Europe and Israel, apart from India.

Scroll down to comment on this story
You can leave a response, or trackback from your own site.

Leave a Reply